European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Background: In an era of increasing use of immunomodulator (IM) therapy, opportunistic infections have emerged as a pivotal safety issue in patients with inflammatory bowel disease (IBD). Today’s challenge to the physician is not only to manage IBD, but also to recognise, prevent and treat common and uncommon infections.

Download PDF